Princeton Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Princeton Capital Management's GILD Position: Q3 2020 in Review
Princeton Capital Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 2,820 shares — an estimated $217K sold.
Princeton Capital Management first reported a position in GILD in Q2 2013 and held it in 25 quarters. The position peaked at $2.46M in Q3 2014. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- Princeton Capital Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
- Princeton Capital Management sold 2,820 Gilead Sciences shares in Q3 2020, an estimated $217K.
- Princeton Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 25 quarters.
- Princeton Capital Management's Gilead Sciences position peaked at $2.46M in Q3 2014.
- 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on Princeton Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.